JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?

BACKGROUND: Population studies showed that patients with JAK2 V617F mutation had increased mortality, and increased risk of any cancer, hematologic cancer, and myeloproliferative disease. CASE PRESENTATION: A 68-year-old Asian male with JAK2 V617F mutation developed four different hematologic and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kenneth G., Verma, Amit, Derman, Olga, Kornblum, Noah, Janakiram, Murali, Braunschweig, Ira, Battini, Ramakrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069777/
https://www.ncbi.nlm.nih.gov/pubmed/27777768
http://dx.doi.org/10.1186/s40364-016-0073-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069777/
https://www.ncbi.nlm.nih.gov/pubmed/27777768
http://dx.doi.org/10.1186/s40364-016-0073-4

Ejemplares similares